Evidence map›Paper›PMID 33035444›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2020

Novel approaches to restore parasympathetic activity to the heart in cardiorespiratory diseases.

Jhansi Dyavanapalli

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Neurovascular interactions in the ageing heart.Nature reviews. Cardiology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Sympathetic neural responses to sleep disorders and insufficiencies.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jhansi DyavanapalliDepartment of Pharmacology and Physiology, George Washington University, Washington, District of Columbia.
George Washington University · US

Funding

Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenationR01HL144157 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI ENTCHEVA, EMILIA, KAY, MATTHEW W. · 2019 to 2022
$2.8M
Hypothalamic neuron activation to blunt myocardial remodeling during chronic sleep apneaR01HL146169 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W. · 2019 to 2022
$2.6M
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial InfarctionR01HL147279 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W., MENDELOWITZ, DAVID · 2020 to 2023
$2.3M
Restoration of Cardiac Parasympathetic Activity in Heart FailureR01HL133862 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI MENDELOWITZ, DAVID · 2016 to 2019
$1.8M
4D Flow MRI-based assessment of atrial fibrillationF30HL137279 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MA, LILIANA · 2017 to 2020
$189k
NHLBI NIH HHS F30 HL137279NHLBI NIH HHS R01 HL133862NHLBI NIH HHS R01 HL144157NHLBI NIH HHS R01 HL146169NHLBI NIH HHS R01 HL147279
6 · The paper itself

Abstract

Neural control of the heart is regulated by sympathetic and parasympathetic divisions of the autonomic nervous system, both opposing each other to maintain cardiac homeostasis via regulating heart rate, conduction velocity, force of contraction, and coronary blood flow. Sympathetic hyperactivity and diminished parasympathetic activity are the characteristic features of many cardiovascular disease states including hypertension, myocardial ischemia, and arrhythmias that result in heart failure. Restoring parasympathetic activity to the heart has recently been identified as the promising approach to treat such conditions. However, approaches that used vagal nerve stimulation have been shown to be unsuccessful in heart failure. This review focuses on novel chemogenetic approaches used to identify the cardioprotective nature of activating neural points along the vagal pathway (both central and peripheral) while being selectively therapeutic in heart failure and obstructive sleep apnea.

Indexed as

AnimalsCholine O-AcetyltransferaseEnzyme ActivatorsHeartHeart FailureHemodynamicsHumansLigandsMuscarinic AgonistsOxytocinReceptors, MuscarinicSleep Apnea, ObstructiveVagus NerveCholine O-AcetyltransferaseEnzyme ActivatorsLigandsMuscarinic AgonistsOxytocinReceptors, Muscarinicchemogeneticcholinergicoxytocinparasympatheticvagus

Identifiers

PMID33035444
PMCPMC7792713
OpenAlexW3092581475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.